Introduction
Controller (C) proteins have been identified in many restrictionmodification (R-M) systems and play a vital role in the temporal regulation of R-M genes. These helix-turn-helix proteins have been shown to act as regulators of both their own transcription and that of the restriction endonuclease (ENase) encoded within the same operon. In some cases, C proteins also regulate transcription of the methyltransferase (MTase; Tao et al., 1991; Ives et al., 1992; Rimšelienė et al., 1995; Lubys et al., 1999; Č esnavičienė et al., 2003; Semenova et al., 2005; Bogdanova et al., 2008) .
Controller proteins have recently been categorized on the basis of ten distinct DNA-recognition motifs (Sorokin et al., 2009) . To date, the structures of three C proteins have been reported (McGeehan et al., 2005 (McGeehan et al., , 2008 Sawaya et al., 2005) ; all are highly homologous proteins with similar folds and with similar DNA-recognition sites. Other groups, such as that exemplified by C.Csp231I and C.EcoO109I, have very different recognition sites and their structures are currently unknown. Kita et al. (2002) have previously identified the recognition sequence of C.EcoO109I as a 15 bp sequence comprising two palindromic pentanucleotides separated by a nonbinding pentanucleotide sequence, 5 0 -CTAAG(N 5 )CTTAG-3 0 , located 47 bp upstream of the C gene start codon. This conforms to the sequence motif identified for both C.Csp231I and C.EcoO109I by bioinformatic analysis (Sorokin et al., 2009) .
In the present paper, we report the expression, purification and characterization of C.Csp231I together with preliminary crystallization and diffraction analysis.
Materials and methods

Cloning and expression
The gene csp231IC (Genbank ID AY787793.1) encoding the putative 98-amino-acid controller protein C.Csp231I was synthesized and subcloned into the expression vector pET-11a by GenScript (Piscataway, New Jersey, USA). The resultant expression vector was transformed into Escherichia coli BL21 (DE3) Gold cells. A single colony was added to 15 ml 2ÂYT medium containing 100 mg ml À1 ampicillin and cultured overnight at 310 K while shaking at 225 rev min À1 . A 10 ml aliquot of the starter culture was used to inoculate 1 l 2ÂYT medium containing 100 mg ml À1 ampicillin and the culture was incubated at 310 K (with shaking at 225 rev min À1 ) until the A 600 reached $0.6, whereupon 1 mM isopropyl -d-1-thiogalactopyranoside (IPTG) was added to induce protein expression. The culture was incubated with shaking for a further 3 h prior to cell harvesting by centrifugation.
Purification
All purifications were performed at 277 K. The harvested cells were suspended in a buffer consisting of 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM EDTA, 3 mM DTT and disrupted by sonication. Following centrifugation (39 191g, 30 min, 277 K) , the supernatant was loaded onto a 5 ml HiTrap heparin HP column (GE Healthcare) and eluted with a 0.1-1 M NaCl gradient. Fractions containing the target protein were pooled and dialysed against 5 l buffer A (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM DTT). Following centrifugation (27 216g, 30 min, 277 K), the supernatant was loaded onto a 1 ml HiTrap SP HP column (GE Healthcare) and eluted with a 0.1-1 M NaCl gradient. Fractions containing the target protein were pooled and dialysed against buffer A (as above) containing 500 mM NaCl to reduce interactions between the target protein and contaminants. The dialysate was loaded onto a HiPrep 26/60 Sephacryl S-100 HR (GE Healthcare) column using buffer A with NaCl added to a final concentration of 500 mM. The purified protein was then pooled and dialysed against 5 l buffer A prior to concentration using a 1 ml HiTrap SP HP column (GE Healthcare) with a 0.1-1 M NaCl step gradient. Following a final dialysis step to reduce the NaCl concentration to 100 mM, the protein concentration was determined by UV spectroscopy using an extinction coefficient calculated from the amino-acid sequence of the monomer of
Dynamic light scattering
Dynamic light scattering (DLS) was performed on a C.Csp231I sample at 1.4 mg ml À1 in 40 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA at 293 K using a Protein Solutions DynaPro temperature-controlled microsampler. The technique provides an estimate of the particle hydrodynamic radius (R h ) and solution molecular weight, as well as the polydispersity of the sample, by analysis of the autocorrelation function. For globular proteins, the value of R h can be used to estimate the molecular mass M r using the empirical equation
Electrophoretic mobility-shift assay
Electrophoretic mobility-shift assays (EMSA) were performed using nondenaturing gel electrophoresis. Two complementary DNA strands corresponding to the region upstream of the C.Csp1396I gene were purchased (Eurogentec), one of which was labelled with the fluorescent tag hexachlorofluorescein (hex), and the two strands were annealed to form a duplex. Aliquots of C.Csp231I were incubated with 800 nM hex-labelled 96 bp DNA duplex in binding buffer (50 mM Tris-HCl pH 8.0) at 277 K for 30 min. The samples were loaded onto a pre-run 5% native polyacrylamide gel and run at 100 V for 150 min. The gels were then scanned using an FLA-5000 imaging system (FujiFilm).
Crystallization
Crystallization conditions were screened by the hanging-drop vapour-diffusion method using the PACT screen kit (Molecular Dimensions) at 289 K. Drops were prepared by mixing 2 ml reservoir solution with 2 ml 1.2 mg ml À1 protein in dialysis buffer and were equilibrated by vapour diffusion against the reservoir solution.
X-ray diffraction analysis
Crystals were cryoprotected by transfer to crystallization solution containing 30%(v/v) glycerol prior to cryocooling in liquid nitrogen. Initial indexing suggested that the space group was primitive monoclinic and therefore a 180 data set was collected from a single crystal (of approximate dimensions 100 Â 80 Â 15 mm) with an oscillation width of 0.5 on beamline I02 of the Diamond Light Source, UK. Data extending to 2.0 Å were collected using an ADSC Q315 CCD detector and processing was performed with MOSFLM (Leslie, 1992) and SCALA (Collaborative Computational Project, Number 4, 1994). Data-collection statistics are given in Table 1 .
Sequence analysis
Amino-acid sequence alignment was carried out using the T-Coffee web server (Armougom et al., 2006) program (Gouet et al., 1999) using the MultAlin similarity function with a 0.7 global score value. Secondary-structure prediction was carried out using the ProteinPredict server (Rost et al., 2004) .
Results and discussion
Amino-acid sequence alignment of C.Csp231I and C.AhdI revealed distinct regions of homology, particularly in the core of the protein (Fig. 1) . Overall, the amino-acid sequence identity between these two proteins was 29% over 62 core residues. The main differences in the C.Csp231I sequence were a 12-amino-acid truncation at the N-terminus, a four-amino-acid insertion adjacent to the predicted helix-turn-helix motif and a 32-amino-acid extension of the C-terminal region. The ProteinPredict program was used to estimate the secondary structure of C.Csp231I. The five characteristic helices conserved among the known C-protein structures were predicted, together with two additional helices located in the extended C-terminal region. Given the significant differences between C.Csp231I and the controller protein structures known to date, both in terms of protein structure and DNA-recognition sequence, we decided to embark on a structural analysis of the C.Csp231I protein.
The controller protein C.Csp231I was overexpressed in E. coli and purified to homogeneity with a final yield of 5 mg l À1 (Fig. 2a) . The molecular mass of the protein was measured as 11 360 Da by electrospray mass spectrometry (University of Leeds, England), which is within 1 Da of that predicted from the amino-acid sequence. The hydrodynamic radius of the protein was measured as 2.4 nm by dynamic light scattering (Fig. 2b) , from which an estimated molecular mass of 27 kDa was obtained, suggesting that C.Csp231I forms homodimers in solution.
In order to confirm the biological activity of the putative transcriptional regulator, its DNA-binding activity was assessed by an electrophoretic gel mobility assay (EMSA), using as substrate a hexlabelled 96 bp oligonucleotide corresponding to a region located directly upstream of the csp231IC start codon. Strong binding was observed, with a full shift at a protein:DNA ratio of 4:1 (Fig. 3) , suggesting that two protein dimers may interact with this DNA sequence.
The crystallization conditions for C.Csp231I were obtained using the PACT screen (Molecular Dimensions Ltd) and were optimized to produce a number of single crystals suitable for X-ray analysis. Single plate-like crystals of approximately 100 mm in length were observed after one month in reservoir conditions consisting of 0.1 M malate-MES-Tris (MMT) pH 7.0 and 20%(w/v) polyethylene glycol (PEG) 1500. The best crystals diffracted to 1.8 Å resolution (Fig. 4) , although diffraction was anisotropic and the crystals diffracted less well in other directions. Nevertheless, by probing the crystal to determine the optimum collection volume a complete data set could be collected to 2.0 Å resolution. The data were processed in space group P2 1 and a self-rotation function analysis was performed using MOLREP (Vagin & Teplyakov, 1997) . The plot at = 180 reveals peaks additional to those resulting from the crystallographic 2 1 screw axis, indicating the presence of a noncrystallographic twofold-symmetry axis (Fig. 5) . This suggests that C.Csp231I forms a dimer in the asymmetric unit of this crystal form, in common with other solved C-protein structures, resulting in a calculated Matthews coefficient of 2.01 Å 3 Da À1 (Matthews, 1968) . Phase determination by molecular replacement has so far been unsuccessful. This may be an indication of significant differences in the structure of C.Csp231I compared with the three available search models C.AhdI (McGeehan et al., 2005) , C.Esp1396I (McGeehan et al., 2008) and C.BclI (Sawaya et al., 2005) . Indeed, such differences in structure would not be surprising given the presence of the 33-aminoacid extension and 12-amino-acid deletion at the C-and N-termini, respectively. Further attempts to solve the structure by molecular replacement, or if necessary by MAD, are in progress in order to provide detailed structural information on this new class of controller proteins.
